You are viewing a free summary from Descrybe.ai. For citation checking, legal issue analysis, and other advanced tools, explore our Legal Research Toolkit — not free, but close.

Freeman v. E. I. du Pont de Nemours & Co. (In re E. I. Du Pont De Nemours & Co. C-8 Personal Injury Litig.)

Citation: 348 F. Supp. 3d 680Docket: Civil Action 2:13-md-2433

Court: District Court, S.D. Ohio; May 12, 2016; Federal District Court

Narrative Opinion Summary

This case is part of a multidistrict litigation (MDL) concerning claims of personal injury and wrongful death from exposure to perfluorooctanoic acid (C-8) contaminated drinking water, linked to DuPont's manufacturing processes. The plaintiff, a member of the Leach Class, alleges his testicular cancer was caused by C-8 exposure. The litigation is guided by the Leach Settlement Agreement, which allows class members to pursue claims for diseases with a Probable Link Finding without contesting general causation, but permits disputes over specific causation. The court evaluates the admissibility of expert testimony under the Daubert standard, requiring relevance and reliability. Plaintiff's expert, Dr. Bahnson, asserts C-8 exposure significantly contributed to the plaintiff's cancer, while DuPont's experts challenge this with opinions on historical scientific knowledge and alternative causes. The court grants partial exclusion of DuPont's expert testimony, emphasizing that causation opinions must adhere to reliable methodologies, such as differential diagnosis, to be admissible. The court’s decision reflects the complexities of causation analysis under the settlement's unique procedures, differing from typical toxic tort standards, and underscores the procedural requirements for changing positions on causation arguments before trial.

Legal Issues Addressed

Causation in Multidistrict Litigation (MDL) under Settlement Agreements

Application: Under the Leach Settlement Agreement, the presence of a Probable Link Finding allows class members to pursue claims without contesting general causation; specific causation remains disputable by the defendant.

Reasoning: Consequently, class members with Linked Diseases may pursue personal injury and wrongful death claims against DuPont without contesting general causation, although DuPont retains the right to dispute specific causation.

Differential Diagnosis as a Method for Establishing Causation

Application: A differential diagnosis must reliably include and exclude potential causes to establish causation; failure to employ such methodology renders expert causation opinions inadmissible.

Reasoning: The Sixth Circuit recognizes differential diagnosis as a valid method for establishing causation in individual cases, noting it involves eliminating possible causes until the most probable one is identified.

Expert Testimony Admissibility under Daubert Standard

Application: The court evaluates the relevance and reliability of expert testimony under the Daubert standard and Federal Rule of Evidence 702, ensuring a proper 'fit' between the testimony and case issues.

Reasoning: The legal framework guiding this matter is established by the Supreme Court in Daubert v. Merrell Dow Pharmaceuticals, which dictates that expert witness testimony must be relevant and reliable under Federal Rules of Evidence, specifically Rules 702 and 104(a).

Relevance and Reliability of Expert Opinions on Historical Scientific Knowledge

Application: Expert testimony on the historical state of science prior to specific findings is admissible if limited to what was known during that period, as it pertains to the defendant's foresight of potential harm.

Reasoning: DuPont argues that Drs. Schoenberg and Luongo may testify about the historical state of science before the Science Panel's findings, which the Court permits, limiting their testimony to what DuPont knew during that period.